New Predictive Marker for Pancreatic Cancer Using CA19-9 and Fecal Elastase
Clinical trial NCT05923567 · UNKNOWN
Trial details
- NCT number
- NCT05923567
- Sponsor
- Gangnam Severance Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-18
- Primary completion
- 2024-12-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.